Impact of congestive heart failure and role of cardiac biomarkers in COVID-19 patients: A systematic review and meta-analysis
2020 · Indian Heart Journal · 39 citations
https://doi.org/10.1016/j.ihj.2020.12.002
S
Sagar Ranka
Citigroup(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
157
Papers
1.3K
Citations
20
h-index
36
i10-index
Sagar Ranka is an academic researcher from Citigroup. The author has contributed to research in topics: Cardiac Structural Anomalies and Repair & Mechanical Circulatory Support Devices & Cardiac Valve Diseases and Treatments. The author has an h-index of 20, co-authored 134 publications.
ORCID: 0000-0002-2167-6961Papers by this author
worksStereotactic cardiac radiotherapy for refractory ventricular tachycardia in structural heart disease patients: a systematic review
2024 · EP Europace · 15 citations
https://doi.org/10.1093/europace/euae305
Electrocardiographic prediction of left ventricular hypertrophy in women and men with left bundle branch block – Comparison of QRS duration, amplitude and voltage-time-integral
2023 · Journal of Electrocardiology · 9 citations
https://doi.org/10.1016/j.jelectrocard.2023.03.004
Accuracy in dosimetry of diagnostic agents: impact of the number of source tissues used in whole organ S value-based calculations
2020 · EJNMMI Research · 3 citations
https://doi.org/10.1186/s13550-020-0614-6
Orthostatic variation of pulmonary artery pressure in ambulatory heart failure patients
2023 · BMC Cardiovascular Disorders · 0 citations
https://doi.org/10.1186/s12872-023-03534-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat